Latest article
Give Conventional Recipes A Higher-For-You Twist
(NAPSI) - Heart disease is the leading killer of men, women, and people of most races and ethnic groups in the United States -...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Surging COVID instances, ‘jingle jabs’ make for somber Christmas | Well being and Health
While some countries in Asia imposed restrictions in an attempt to contain the highly contagious variant of omicron, governments in Europe, the United States,...